Sathornviriyapong S.; Matsuda A.; Miyashita M.; Matsumoto S.; Sakurazawa N.; Kawano Y.; Yamada M.; Uchida E.
(2016)
Background: Neoadjuvant chemoradiation (NCRT) has emerged as a component of the standard treatment for esophageal squamous cell carcinoma (SCC). The primary benefit of NCRT is an improvement in long-term survival; however, ...